Skip to Content

Clinical Trials Search Results

Showing 1-3 of 3

Sorted By:

  • LCCC 1029

    A Multi-Center, Randomized, Placebo-Controlled Phase II Study of Regorafenib in Combination with FOLFIRI (Irinotecan, 5-Fluorouracil, and Leucovorin) Versus Placebo with FOLFIRI as Second-Line Therapy in Patients with K-RAS or BRAF Mutant Metastatic Colorectal Cancer

  • LCCC 1317

    Genotype-Directed Phase II Study Of Higher Dose Of Irinotecan In First-Line Metastatic Colorectal Cancer Patients Treated With FOLFIRI Plus Bevacizumab


    Patient Registry and Biospecimens Profiling Repository

Showing trials 1-3 of 3

Also in this Section